The Patent Finder

Lipids and Lipid Compositions for the Delivery of Active Agents

Novartis AG

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 4 of these applications claim priority to application 61/774,759, filed Mar 8, 2013. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 10,124,065Lipids and Lipid Compositions for the Delivery of Active Agents
In force
 · High confidence
UsedRemaining
Novartis AGIn forceHigh confidence
US 10,792,361Lipids and Lipid Compositions for the Delivery of Active Agents
In force
 · High confidence
Novartis AGIn forceHigh confidence
US 9,504,747Lipids and Lipid Compositions for the Delivery of Active Agents
In force
 · High confidence
Novartis AGIn forceHigh confidence
US 10,729,775Lipids and Lipid Compositions for the Delivery of Active Agents
In force
 · Medium confidence
Novartis AGIn forceMedium confidence
US 10,227,5883'END CAPS FOR RNAi AGENTS FOR USE IN RNA INTERFERENCE
In force
 · High confidence
Novartis AGIn forceHigh confidence
US 10,519,446Organic Compounds to Treat Hepatitis B Virus
In force
 · High confidence
Novartis AGIn forceHigh confidence
US 11,008,5703'END CAPS FOR RNAi AGENTS FOR USE IN RNA INTERFERENCE
In force
 · High confidence
Novartis AGIn forceHigh confidence
US 9,988,627Novel Formats for Organic Compounds for Use in RNA Interference
In force
 · High confidence
Novartis AGIn forceHigh confidence
US 10,059,655Lipids and Lipid Compositions for the Delivery of Active Agents
In force
 · High confidence
Novartis AGIn forceHigh confidence
US 10,906,867Lipids and Lipid Compositions for the Delivery of Active Agents
In force
 · High confidence
Novartis AGIn forceHigh confidence
7 more records in this group · Pro
10 of 17 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 17.
Upgrade to Pro
16 of these are in force and held by Novartis AG.
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited